UCSF Clinical Drug Trial for Acute Mountain Sickness The Sall Lab at UCSF, has completed a Phase 2 FDA clinical drug trial to determine the effectiveness of a new drug for AMS(Acute Mountain Sickness) called T89. Status: Completed